These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Postbiotics in colorectal cancer: intervention mechanisms and perspectives. Xie W; Zhong YS; Li XJ; Kang YK; Peng QY; Ying HZ Front Microbiol; 2024; 15():1360225. PubMed ID: 38450163 [TBL] [Abstract][Full Text] [Related]
9. Postbiotic as Novel Alternative Agent or Adjuvant for the Common Antibiotic Utilized in the Food Industry. Sepordeh S; Jafari AM; Bazzaz S; Abbasi A; Aslani R; Houshmandi S; Rad AH Curr Pharm Biotechnol; 2024; 25(10):1245-1263. PubMed ID: 37702234 [TBL] [Abstract][Full Text] [Related]
10. Potential Pharmaceutical and Food Applications of Postbiotics: A Review. Rad AH; Abbasi A; Kafil HS; Ganbarov K Curr Pharm Biotechnol; 2020; 21(15):1576-1587. PubMed ID: 32416671 [TBL] [Abstract][Full Text] [Related]
11. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies. Ha S; Zhang X; Yu J Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348 [TBL] [Abstract][Full Text] [Related]
12. A novel bioactive postbiotics: from microbiota-derived extracellular nanoparticles to health promoting. Gu Z; Meng S; Wang Y; Lyu B; Li P; Shang N Crit Rev Food Sci Nutr; 2023; 63(24):6885-6899. PubMed ID: 35179102 [TBL] [Abstract][Full Text] [Related]
13. Postbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications. Wang S; Wang P; Wang D; Shen S; Wang S; Li Y; Chen H J Sci Food Agric; 2025 Jan; 105(2):721-734. PubMed ID: 39007163 [TBL] [Abstract][Full Text] [Related]
14. Gut microbiota modulation: a tool for the management of colorectal cancer. Wang Y; Li H J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107 [TBL] [Abstract][Full Text] [Related]
15. Postbiotics as potential promising tools for SARS-CoV-2 disease adjuvant therapy. Khani N; Abedi Soleimani R; Noorkhajavi G; Abedi Soleimani A; Abbasi A; Homayouni Rad A J Appl Microbiol; 2022 Jun; 132(6):4097-4111. PubMed ID: 35064987 [TBL] [Abstract][Full Text] [Related]
16. The clinical evidence for postbiotics as microbial therapeutics. Mosca A; Abreu Y Abreu AT; Gwee KA; Ianiro G; Tack J; Nguyen TVH; Hill C Gut Microbes; 2022; 14(1):2117508. PubMed ID: 36184735 [TBL] [Abstract][Full Text] [Related]
17. Postbiotics as Adjuvant Therapy in Cancer Care. Balendra V; Rosenfeld R; Amoroso C; Castagnone C; Rossino MG; Garrone O; Ghidini M Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125280 [TBL] [Abstract][Full Text] [Related]
18. New clues for postbiotics to improve host health: a review from the perspective of function and mechanisms. Yan R; Zeng X; Shen J; Wu Z; Guo Y; Du Q; Tu M; Pan D J Sci Food Agric; 2024 Aug; 104(11):6376-6387. PubMed ID: 38450745 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer. Cheraghpour M; Fatemi N; Shadnoush M; Talebi G; Tierling S; Bermúdez-Humarán LG Med Oncol; 2024 Aug; 41(9):231. PubMed ID: 39162936 [TBL] [Abstract][Full Text] [Related]
20. Microbe-based management for colorectal cancer. Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]